| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_CADPS2_0016600 | Intron-Exon-Intron | chr7:122221233-122263074 | chr7:122581179-122623020 | 112 nt | 0.5179 |
| hsa_CADPS2_0016700 | Intron-Exon-Intron | chr7:122221233-122264730 | chr7:122581179-122624676 | 112 nt | 0.5179 |
| hsa_CADPS2_0016800 | Exon-Exon | chr7:122221233-122303623 | chr7:122581179-122663569 | 796 nt | 0.4234 |
| hsa_CADPS2_0016900 | Exon-Exon | chr7:122221233-122377122 | chr7:122581179-122737068 | 120 nt | 0.4500 |
| hsa_chr7_0100000 | Intergenic-Intergenic | chr7:122245267-122297008 | chr7:122605213-122656954 | 250 nt | 0.3040 |
| hsa_CADPS2_0017000 | Intron-Exon-Intron | chr7:122248982-122261771 | chr7:122608928-122621717 | 93 nt | 0.5054 |
| hsa_CADPS2_0017100 | Intron-Exon-Intron | chr7:122254683-122304086 | chr7:122614629-122664032 | 1785 nt | 0.3832 |
| hsa_CADPS2_0017500 | Intron-Exon-Intron | chr7:122255235-122257584 | chr7:122615181-122617530 | 72 nt | 0.3889 |
| hsa_CADPS2_0017400 | Exon-Exon | chr7:122255235-122261615 | chr7:122615181-122621561 | 200 nt | 0.4500 |
| hsa_CADPS2_0017600 | Exon-Exon | chr7:122255235-122261771 | chr7:122615181-122621717 | 422 nt | 0.3957 |
A review of studies in humans, mice, and rats indicates that the circCADPS2 demonstrates stable expression in myocardial tissue and body fluids, with specific expression patterns associated with sudden cardiac death-related diseases [Tian et al. DOI:10.3390/molecules26041155]. A study in human traumatic brain injury (TBI) patients identified the circCADPS2 as a top up-regulated circular RNA (fold change 17.62) in brain injury tissues compared to adjacent contusion tissues, with its increased expression validated by qRT-PCR [Li et al. DOI:10.3389/fneur.2022.1086553].